149 related articles for article (PubMed ID: 37563954)
21. Co-encapsulation of magnetic Fe
Liang C; Li N; Cai Z; Liang R; Zheng X; Deng L; Feng L; Guo R; Wei B
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4211-4221. PubMed ID: 31713444
[TBL] [Abstract][Full Text] [Related]
22. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732
[TBL] [Abstract][Full Text] [Related]
23. Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy.
Lin X; Cao Y; Li J; Zheng D; Lan S; Xue Y; Yu F; Wu M; Zhu X
Biomater Sci; 2019 Jul; 7(7):2996-3006. PubMed ID: 31111139
[TBL] [Abstract][Full Text] [Related]
24. Synergistic Theranostics of Magnetic Resonance Imaging and Photothermal Therapy of Breast Cancer Based on the Janus Nanostructures Fe
Kang X; Sun T; Zhang L; Zhou C; Xu Z; Du M; Xiao S; Liu Y; Gong M; Zhang D
Int J Nanomedicine; 2021; 16():6383-6394. PubMed ID: 34556986
[TBL] [Abstract][Full Text] [Related]
25. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
Cui T; Zhang S; Sun H
Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
[TBL] [Abstract][Full Text] [Related]
26. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
27. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
[TBL] [Abstract][Full Text] [Related]
28. Nano-delivery vehicle based on chlorin E6, photodynamic therapy, doxorubicin chemotherapy provides targeted treatment of HER-2 negative, ανβ3-positive breast cancer.
He Z; Jiang H; Zhang X; Zhang H; Cui Z; Sun L; Li H; Qian J; Ma J; Huang J
Pharmacol Res; 2020 Oct; 160():105184. PubMed ID: 32946931
[TBL] [Abstract][Full Text] [Related]
29. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line.
Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA
Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815
[No Abstract] [Full Text] [Related]
30. Heterogeneous dimer peptide-conjugated polylysine dendrimer-Fe
Shen JM; Li XX; Fan LL; Zhou X; Han JM; Jia MK; Wu LF; Zhang XX; Chen J
Int J Nanomedicine; 2017; 12():1183-1200. PubMed ID: 28243083
[TBL] [Abstract][Full Text] [Related]
31. [Preliminary study of breast cancer magnetic resonance targeting diagnosis basing on magnetic nanoparticles in vitro].
Luo XF; Wu JT; Qu QX; Hu XH; Chen MX; Chen WX; Dong Y; Jiang L
Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(35):2830-3. PubMed ID: 24360184
[TBL] [Abstract][Full Text] [Related]
32. Targeted Fe-doped silica nanoparticles as a novel ultrasound-magnetic resonance dual-mode imaging contrast agent for HER2-positive breast cancer.
Li X; Xia S; Zhou W; Ji R; Zhan W
Int J Nanomedicine; 2019; 14():2397-2413. PubMed ID: 31040664
[TBL] [Abstract][Full Text] [Related]
33. Magnetically responsive peptide coacervates for dual hyperthermia and chemotherapy treatments of liver cancer.
Lim ZW; Varma VB; Ramanujan RV; Miserez A
Acta Biomater; 2020 Jul; 110():221-230. PubMed ID: 32422317
[TBL] [Abstract][Full Text] [Related]
34. Novel nanomedicine with a chemical-exchange saturation transfer effect for breast cancer treatment in vivo.
Jia Y; Wang C; Zheng J; Lin G; Ni D; Shen Z; Huang B; Li Y; Guan J; Hong W; Chen Y; Wu R
J Nanobiotechnology; 2019 Dec; 17(1):123. PubMed ID: 31847857
[TBL] [Abstract][Full Text] [Related]
35. Nonmagnetic Hypertonic Saline-Based Implant for Breast Cancer Postsurgical Recurrence Prevention by Magnetic Field/pH-Driven Thermochemotherapy.
Gao F; Zhang T; Liu X; Ghosal A; Wang D; Xie W; Li Y; Wang X; Tao L; Yu J; Wei Y; Fan HM; Zhao L
ACS Appl Mater Interfaces; 2019 Mar; 11(11):10597-10607. PubMed ID: 30802401
[TBL] [Abstract][Full Text] [Related]
36. A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy.
Shi J; Wang B; Chen Z; Liu W; Pan J; Hou L; Zhang Z
Pharm Res; 2016 Jun; 33(6):1472-85. PubMed ID: 26984128
[TBL] [Abstract][Full Text] [Related]
37. A tumor-specific cleavable nanosystem of PEG-modified C60@Au hybrid aggregates for radio frequency-controlled release, hyperthermia, photodynamic therapy and X-ray imaging.
Shi J; Chen Z; Wang L; Wang B; Xu L; Hou L; Zhang Z
Acta Biomater; 2016 Jan; 29():282-297. PubMed ID: 26485168
[TBL] [Abstract][Full Text] [Related]
38. Efficient Magnetic Nanocatalyst-Induced Chemo- and Ferroptosis Synergistic Cancer Therapy in Combination with T
Zhu L; Wang J; Tang X; Zhang C; Wang P; Wu L; Gao W; Ding W; Zhang G; Tao X
ACS Appl Mater Interfaces; 2022 Jan; 14(3):3621-3632. PubMed ID: 35005898
[TBL] [Abstract][Full Text] [Related]
39. Controlled release of doxorubicin from polyethylene glycol functionalized melanin nanoparticles for breast cancer therapy: Part I. Production and drug release performance of the melanin nanoparticles.
Ozlu B; Kabay G; Bocek I; Yilmaz M; Piskin AK; Shim BS; Mutlu M
Int J Pharm; 2019 Oct; 570():118613. PubMed ID: 31415880
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
